Yan Wang, Ph.D. (she/her/hers)

Deputy Division Director
US Food and Drug Administration

Poster(s):

• (M0930-07-42) Beyond Particle Size: Impact of Milling Techniques on Agglomeration Behavior and In Vitro Performance of Long-Acting Injectable Suspensions
  Monday, November 10, 2025

  9:30 AM - 10:30 AM CT

• (M1030-06-37) Predicting Drug Release from EVA-Based Long-Acting Implants: Mechanisms, Modeling, and Simulation of Drug Release
  Monday, November 10, 2025

  10:30 AM - 11:30 AM CT

• (W1030-06-39) Impact of Ionizable Lipid Source on the In Vitro Performance of siRNA Loaded Lipid Nanoparticles
  Wednesday, November 12, 2025

  10:30 AM - 11:30 AM CT

• (M1030-06-39) Impact of Polyethylene Glycol Polymer in the Development of Long-Acting Injectable Suspensions
  Monday, November 10, 2025

  10:30 AM - 11:30 AM CT

• (M1130-06-37) Revolutionizing Women’s Health by Enabling the Rational Development of Long-Acting Contraceptive Levonorgestrel Intrauterine Systems
  Monday, November 10, 2025

  11:30 AM - 12:30 PM CT

• (M1230-06-36) In Situ Forming Implants: The Effect of Drug-Polymer-Solvent Interplay on Depot Behavior
  Monday, November 10, 2025

  12:30 PM - 1:30 PM CT

• (T1430-07-46) Advanced Characterization of Injectafer^®: Carboxymaltose Structure, Iron Core Structure, and Interaction of Carboxymaltose with Iron Core
  Tuesday, November 11, 2025

  2:30 PM - 3:30 PM CT